Health Care Symposium

Daniel Kraft is a Stanford and Harvard-trained physician-scientist, inventor, entrepreneur, and investor. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as faculty chair for Medicine at Singularity University since its inception in 2008 and is founder and chair of NextMed Health (the evolution of Exponential Medicine), a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.

He is a General Partner with Continuum Health Ventures, funding and catalyzing early-stage health tech and health span focused startups. Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children’s Hospital, and Stanford fellowships in hematology, oncology, and bone marrow transplantation.

He has multiple scientific publications (including in Nature and Science) and medical device, immunology, stem cell and digital health related patents through NIH-funded faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at the University of California San Francisco.

Daniel is a member of the Inaugural class of the Aspen Institute Health Innovators Fellowship and is a member of the Kauffman Fellows Society. He is often called upon to speak to the future of health, medicine and technology and has given four TED and two TEDMED Talks and has delivered keynotes to a diverse array of organizations. He also serves as chair of the XPRIZE Pandemic & Health Alliance and Health Brain Trust.

He is heavily involved in healthtech, founded Digital.Health, and is on the board of several Fortune-50 and digital health-related startups. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies.

Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeon with F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.

Colby is the Chief Technology Officer and co-founder of Darroch Medical Solutions. Colby and his team are developing a revolutionary AI-powered remote monitoring platform, the Beat Analytics System, which uses high-frequency, multi-instrument data to proactively identify at-risk patients and deliver insights to healthcare providers. With extensive expertise in medical device interoperability and AI, Colby is driving Darroch’s mission to improve patient outcomes and reduce adverse events. His work is helping shape the future of healthcare by bringing advanced, AI-driven solutions to the forefront of patient care.

Darroch Medical Solutions is a Stead Impact Ventures portfolio company. Stead Impact Ventures invests in innovators whose ideas will positively change the course of healthcare.

Angie Danielson is committed to bringing clarity to pharmacy benefits. As vice president of operations at Vivid Clear Rx, a pass-through pharmacy benefit manager owned by Hy-Vee, Angie’s mission is to deliver transparent pricing to employers and superior care and service to its members. Angie has been serving pharmacy patients for more than 20 years, beginning her career in Hy-Vee’s retail pharmacies where she became a licensed pharmacist and later was selected to lead a region of Hy-Vee’s pharmacies as pharmacy supervisor. In 2024, she joined the Vivid Clear Rx team to lead operations. Angie received her undergraduate degree from Wartburg College and earned her Doctor of Pharmacy at the University of Iowa.